Healsun Biopharm
Latest round
- Series C
Last raised
- Nov 2025
Total raised
- $77M
Investors
- 12
About Healsun Biopharm
Based in Hangzhou, China and established in 2015, Healsun Biopharm is a pharmaceutical company that focuses on technology for antibody and recombinant protein drug development. The company has R&D centers and manufacturing facilities in Shanghai and Hangzhou. As of 2023, it has more than 180 employees. The company provides biopharmaceutical technology research and development services including antibody drug analysis, protein transient expression, antibody recombinant protein CMC development (stable cell line development, fermentation process development, purification process development, protein analysis method development and pilot production), antibody-conjugated drugs (ADCs) development and other technologies. In 2024 the company will have six 2,000L drug discovery and development lines in operation.
Who invested in Healsun Biopharm
12 investors across 4 rounds
See all investors in Healsun Biopharm
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Healsun Biopharm
Who invested in Healsun Biopharm?
Healsun Biopharm has 12 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Healsun Biopharm raised?
Healsun Biopharm has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Healsun Biopharm last raise money?
Healsun Biopharm's most recent round on record is a Series C, in Nov 2025.
What does Healsun Biopharm do?
Based in Hangzhou, China and established in 2015, Healsun Biopharm is a pharmaceutical company that focuses on technology for antibody and recombinant protein drug development.
Where is Healsun Biopharm headquartered?
Healsun Biopharm is headquartered in Hangzhou, China.
Which VCs invest in companies like Healsun Biopharm?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Healsun Biopharm's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Healsun Biopharm? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.